Abnova (Taiwan) Corporation (TWSE: 4133)
Health Care · Life Sciences Tools & Services · TW
NT$22.65
+10.76% today · -12.9% 1Y
Abnova (Taiwan) Corporation (TWSE: 4133) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $42.89M and employs 110 people.
Over the last twelve months the share price has lost 12.9%, trading between 20.00 and 29.15.
Tweenvest scores Abnova (Taiwan) Corporation across four factors: quality 79/100, value 75/100, growth 0/100, dividend 16/100. Its strongest factor is quality.
4133 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $42.89M
- Revenue (TTM)
- $10.86M
- P/E
- 30.61
- EPS
- 0.74
- Dividend yield
- 0.49%
- Beta (5Y)
- 0.27
- 52-week high
- NT$29.15
- 52-week low
- NT$20.00
- Avg volume (3M)
- —
- Shares outstanding
- 60.55M
- Employees
- 110
- Next earnings
- —
About Abnova (Taiwan) Corporation
Abnova (Taiwan) Corporation specializes in the development and distribution of a comprehensive range of recombinant proteins and antibodies. The company's extensive product portfolio caters to diverse research and diagnostic applications, featuring specialized reagents for SARS-CoV/CoV-2, nucleic acids (both DNA and RNA), and various proteins and peptides. Their offerings further include items like DNAxPab, laboratory beads, dyes, cellular lysates, microscopic slides, antibody pairs and associated kits, as well as antibody and tissue arrays. Additionally, they provide in situ hybridization products, advanced laboratory systems and automation, GMP-grade and analyte-specific reagents, and solutions for in vitro diagnostics. Beyond these product lines, Abnova supplies a broad spectrum of antibody types, such as MaxPab, monoclonal, polyclonal, recombinant, conjugate, secondary/tag, IHC/pathology, and those specifically targeting circulating rare cells. The company also delivers integrated solutions and services, encompassing gene synthesis and cytogenetic analysis, peptide services, protein expression and conjugations, custom antibody generation, and assay development. Abnova (Taiwan) Corporation operates from its headquarters in Taipei, Taiwan.
- ISIN
- TW0004133004
- Founded
- 2002
- Listed since
- Dec 28, 2009
- Exchange
- Taiwan Stock Exchange
- Currency
- TWD
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| ENCell Co., Ltd.KOSDAQ: A456070 | $48.16M | ₩5,870.00 | -2.17% |
| Chiome Bioscience Inc.TSE: 4583 | $46.85M | ¥94.00 | -7.84% |
| Austar Lifesciences LimitedSEHK: 6118 | $45.72M | HK$0.70 | -2.78% |
| Rapid Micro Biosystems, Inc.NasdaqCM: RPID | $44.82M | $0.89 | -2.88% |
| Eone Diagnomics Genome Center Co., Ltd.KOSDAQ: A245620 | $42.41M | ₩— | — |
| Macter International LimitedKASE: MACTER | $41.22M | PKRs249.15 | -1.90% |
| MEDINET Co., Ltd.TSE: 2370 | $41.20M | ¥23.00 | -4.17% |
| QuadMedicine, Inc.KOSDAQ: A464490 | $41.08M | ₩4,810.00 | -6.60% |
Figures last refreshed Oct 11, 2026.